The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
The multifaceted role of reactive oxygen species in tumorigenesis
Open accessAbstract
Redox homeostasis is an essential requirement of the biological systems for performing various normal cellular functions including cellular growth, differentiation, senescence, survival and aging in humans. The changes in the basal levels of reactive oxygen species (ROS) are detrimental to cells and often lead to several disease conditions including cardiovascular, neurological, diabetes and cancer. During the last two decades, substantial research has been done which clearly suggests that ROS are essential for the initiation, progression, angiogenesis as well as metastasis of cancer in several ways. During the last two decades, the potential of dysregulated ROS to enhance tumor formation through the activation of various oncogenic signaling pathways, DNA mutations, immune escape, tumor microenvironment, metastasis, angiogenesis and extension of telomere has been discovered. At present, surgery followed by chemotherapy and/or radiotherapy is the major therapeutic modality for treating patients with either early or advanced stages of cancer. However, the majority of patients relapse or did not respond to initial treatment. One of the reasons for recurrence/relapse is the altered levels of ROS in tumor cells as well as in cancer-initiating stem cells. One of the critical issues is targeting the intracellular/extracellular ROS for significant antitumor response and relapse-free survival. Indeed, a large number of FDA-approved anticancer drugs are efficient to eliminate cancer cells and drug resistance by increasing ROS production. Thus, the modulation of oxidative stress response might represent a potential approach to eradicate cancer in combination with FDA-approved chemotherapies, radiotherapies as well as immunotherapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS play an essential role in carcinogenesis, affecting multiple biological processes, including genomic instability, cell growth, angiogenesis, inflammation, metabolic reprogramming, metastatization, and resistance to apoptosis [77].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [77]
In the citing paper
“Elevated levels of intracellular ROS are known to be one of the reasons for genomic instability and, hence, carcinogenesis [29].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
In the citing paper
“ROS are known to play a multifaced, opposing role in cancer, by favoring cancer onset at low doses on the one hand, and killing tumors at high doses on the other hand [29,55].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
Citations
Cites
2 retracted
Garg, M., Kanojia, D., Mayakonda, A., Ganesan, T. S., Sadhanandhan, B., Suresh, S., Sneha, S., Nagare, R. P., SAID, J. W., Doan, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10325-x · Cited by 48
Self-citationRetractedKanojia, D., Garg, M., Martinez, J., Anand, M. T., Luty, S. B., Doan, N., SAID, J. W., Forscher, C. A., Tyner, J. W., & Koeffler, H. P. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0540-x · Cited by 30
Self-citationRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Cited by
Sorted by citations
Items 201–300 of 452
UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation
Wang, L., Zhao, S., Wang, Y., Liu, J., & Wang, X. (2024) · BMC Cancer · doi:10.1186/s12885-024-12212-x · Cited by 17
“Although elevated ROS plays a crucial role in tumor initiation and progression, the excessive accumulation of ROS incurs oxidative damages and triggers cell death in tumor cells [29].”
BackgroundXanthohumol Induces ROS through NADPH Oxidase, Causes Cell Cycle Arrest and Apoptosis
Wang, C., Chen, J., Zhao, J., Hu, S., Zhang, S., Mi, X., Shi, X., Cao, X., & Li, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9877170 · Cited by 17
Li, Y. R., Kandyba, E. E., Halliwill, K. D., Delrosario, R., Tran, Q., Bayani, N., Wu, D., Mirzoeva, O. K., Reeves, M. Q., Islam, S. M. A., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1379 · Cited by 16
“An important endogenous source of mutations in human tumor genomes is ROS, a broad category of highly reactive oxygen free radicals, including peroxides, superoxide, hydroxyl radical, singlet oxygen, and alpha-oxygen (29).”
Song, Y., Hou, Z., Zhu, L., Chen, Y., & Li, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-02245-4 · Cited by 20
Chen, Q., Wang, J., Li, N., Cai, H., & Lu, Y.-Y. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104924 · Cited by 18
Resta, J., Santin, Y., Roumiguié, M., Riant, É., Lucas, A., Couderc, B. C., Binda, C., Lluel, P., Parini, A., & Mialet‐Perez, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911747 · Cited by 17
“It is well known that cancer cells have increased ROS levels, although the exact cellular sources are not identified, and that they are capable of coping with enhanced oxidative stress to evade cell death through the upregulation of antioxidant defenses [14].”
BackgroundCorynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects
Wen, C., Ruan, Q., Li, Z., Zhou, X., Yang, X., Xu, P., Akuetteh, P. D. P., Xu, Z., & Deng, J. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02002-2 · Cited by 16
“Studies have shown that elevated ROS levels can lead to misfolded proteins and ER stress [31, 32].”
BackgroundZhao, Y., Yu, J., Huang, A., Yang, Q., Li, G., Yang, Y., & Chen, Y. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03003-8 · Cited by 16
“In the context of TME, reactive oxygen species (ROS) are cumulatively elevated in response to the combined stimulus of a hypoxic background and some other adverse stimuli, which are detrimental to treatment [14, 15].”
BackgroundFerreira, R. C., do Nascimento, Y. M., Loureiro, P. B. A., Martins, R. X., Maia, M. E. D. S., Farias, D. F., Tavares, J. F., Gonçalves, J. C. R., da Silva, M. S., & Sobral, M. V. (2023) · Biomolecules · doi:10.3390/biom13101439 · Cited by 18
“However, excessive intracellular ROS concentration leads to irreparable damage and death of tumor cells [105].”
BackgroundRani, N., Sahu, M., Ambasta, R. K., & Kumar, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102174 · Cited by 16
Mao, X., Wang, L., Chen, Z., Huang, H., Chen, J., Su, J., Li, Z., Shen, G., Ren, Y., Li, Z., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133698 · Cited by 16
Jung, Y. Y., Um, J., Sethi, G., & Ahn, K. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179848 · Cited by 16
Self-citationBupivacaine and Lidocaine Induce Apoptosis in Osteosarcoma Tumor Cells
Mirshahidi, S., Shields, T. G., de Necochea-Campion, R., Yuan, X., Janjua, A., Williams, N. L., Mirshahidi, H., Reeves, M. E., Duerksen-Hughes, P. J., & Zuckerman, L. M. (2020) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000001510 · Cited by 16
“Increased cellular levels of ROS cause Bax/Bak channels on themitochondrial membrane to open which release apoptosis-promoting factors into the cytosol and lead to activation of apoptosis and direct damage to nuclear and mitochondrial DNA [26, 42, 51].”
BackgroundLiao, T., Xu, X., Wang, G., & Yan, J. (2025) · BMC Biology · doi:10.1186/s12915-025-02240-9 · Cited by 15
“Upregulation of p53 can reduce system Xc-activity and GSH production and induce ROS and lipid ROS accumulation to mediate ferroptosis [33].”
A brief overview of antitumoral actions of bruceine D
Sin, Z. W., Bhardwaj, V., Pandey, A. K., & Garg, M. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00013 · Cited by 15
“Failure to maintain the dynamic equilibrium between ROS production and ROS elimination would result in oxidative stress to the cell [102, 103].”
BackgroundSelf-citationZhu, Y., Lei, C., Jiang, Q., Yu, Q., & Qiu, L. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02661-4 · Cited by 15
Wen, W., Ertaş, Y. N., Erdem, A., & Zhang, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216857 · Cited by 18
Omran, M. M., Kamal, M. M., Ammar, Y. A., Abusaif, M. S., Ismail, M. M. F., & Mansour, H. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-69250-5 · Cited by 15
“Increasing or reducing intracellular ROS levels could mitigate the conflicting effect of ROS on the development of cancer 39 .”
BackgroundFang, Y., Zhang, Q., Guo, C., Zheng, R., Liu, B., Zhang, Y., & Wu, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1461489 · Cited by 15
“As the center of cellular energy metabolism, mitochondrial dysfunction is not only closely related to the occurrence and progression of cancer (7, 8) but also associated with drug resistance and the maintenance of tumor stem cells (9, 10).”
BackgroundYang, M.-H., Ha, I. J., Um, J., & Ahn, K. (2021) · Biomedicines · doi:10.3390/biomedicines9040362 · Cited by 11
“ROS generally functions as a double-edge sword can function both as tumor promoter and suppressor under different conditions [68,69].”
BackgroundChen, Z., Tai, Y., Deng, C., Sun, Y., Chen, H., Luo, T., Lin, J., Chen, W., Xu, H., Song, G., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123344 · Cited by 14
Mitochondrial Dysfunction in Aging: Future Therapies and Precision Medicine Approaches
Jia, L., Wei, Z., Luoqian, J., Wang, X., & Huang, C. (2025) · MedComm – Future Medicine · doi:10.1002/mef2.70026 · Cited by 14
Muğlu, H., Sönmez, F., Çavuş, M. S., Kurt, B. Z., & Yakan, H. (2022) · Research on Chemical Intermediates · doi:10.1007/s11164-022-04908-1 · Cited by 14
Jaradat, N. A., Dwikat, M., Amer, J., Ghanim, M. A., Hawash, M., Hussein, F., Issa, L., Ishtawe, S., Salah, S., & Nasser, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1351743 · Cited by 14
“Oxidative stress, resulting from an imbalance between the production of reactive oxygen species (ROS) and the body ’ s ability to neutralize them, is implicated in the pathophysiology of obesity, diabetes, and cancer (Crujeiras et al., 2013).”
BackgroundSciaccotta, R., Gangemi, S., Penna, G., Giordano, L., Pioggia, G., & Allegra, A. (2024) · Antioxidants · doi:10.3390/antiox13040475 · Cited by 15
“It necessitates the presence of protein RIPK3 (receptor-interacting protein kinase 1) and its substrate MLKL, which are essential components of this pathway [69].”
Targeting Ferroptosis as an Advance Strategy in Cancer Therapy
Muluh, T. A., Fu, Q., Ai, X., Wang, C., Chen, W., Zheng, X., Wang, W., Wang, M., Shu, X., & Ying, Y. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0608 · Cited by 15
“…such as TP53, RAS, and RB1, which allow the cell to overcome con-trol mechanisms that stop the cell cycle or induce cell death, tumor cells often experience an increase in oxidative stress because of changes in metabolic processes and the surrounding TME (Kirtonia et al., 2020; Wang et al., 2021).”
InfluentialChen, Z., Wang, W., Hou, J., Gao, C., Song, M., Zhao, Z., Guan, R., Chen, J., Wu, H., Razak, S. R. A., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02243-5 · Cited by 15
“For statistical analysis, ESCC cases were divided into NEDD4L or xCT high expression group (score ≥ 4) and low expression group (score < 4).”
Miyata, Y., Mukae, Y., Harada, J., Matsuda, T., Mitsunari, K., Matsuo, T., Ohba, K., & Sakai, H. (2020) · Molecules · doi:10.3390/molecules25225252 · Cited by 14
“There are numerous systematic reviews that have described the detailed pathological significance of ROS in malignant cells, as well as their pharmacological impact in chemotherapy [8,20,37].”
BackgroundBiocompatible tumor-targeted GQDs nanocatalyst for chemodynamic tumor therapy
Wu, Z., Pan, T., Lin, D., Xia, W., Shan, J., Cheng, R., Yang, M., Hu, X., Nan, K., & Qi, L. (2022) · Journal of Materials Chemistry B · doi:10.1039/d1tb02734d · Cited by 14
Ma, S., Ge, Y., Xiong, Z., Wang, Y., Li, L., Chao, Z., Li, B., Zhang, J., Ma, S., Xiao, J., et al. (2023) · PeerJ · doi:10.7717/peerj.14784 · Cited by 13
He, Y., Gong, F., Jin, T., Liu, Q., Fang, H., Chen, Y., Wang, G., Chu, P. K.-H., Wu, Z., & Ostrikov, K. (2023) · Biomolecules · doi:10.3390/biom13040707 · Cited by 14
“These immunosuppressive cells are tolerant to a TME with qualities such as high ROS levels an a low pH, and help tumors to achieve immune escape [60].”
BackgroundZheng, X., Wu, H., Wang, S., Zhao, J., & Hu, L. (2023) · Gels · doi:10.3390/gels9060452 · Cited by 14
“This further leads to cell immortalization and contributes to the necessary conditions for the cells to reach a malignant growth state [18,19].”
BackgroundDai, L., Tian, S., Zhang, J., Lu, M., Zhu, J., & Zhao, H. (2021) · BioMed Research International · doi:10.1155/2021/6650045 · Cited by 14
“angiogenesis, and invasion, while excessive ROS can cause oxidative stress, thus inducing DNA damage and triggering various cellular responses [13, 14].”
BackgroundCurcumin: A potential therapeutic natural product for adenocarcinomas
Nasery, M. M., Varzandeh, M., Pahlavanneshan, S., Mohamadi, N., Sarhadi, S., Fekri, H. S., Mohammadinejad, R., & Ahn, K. S. (2022) · Phytochemistry Letters · doi:10.1016/j.phytol.2022.02.013 · Cited by 14
Review Article on Molecular Basis of Zinc and Copper Interactions in Cancer Physiology
Joshi, A. D., & Mandal, R. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04356-5 · Cited by 14
“However, Zn was exhibited to act as anti-carcinogenic due to its antioxidant properties [41, 53, 107, 117–121].”
Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma
Xia, Y., Wang, D., Piao, Y., Chen, M., Wang, D., Jiang, Z., & Liu, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1025532 · Cited by 13
“Reactive oxygen species (ROS) produced by oxidative stress can activate the NF-kB and Nrf2 pathways, allowing tumour cells to survive (108).”
BackgroundFeng, M., Xiao, S., Liu, Z., Li, M., Zhang, X., Chen, X., Zhang, Y., Chen, B., & Liu, J. (2023) · Materials Today Nano · doi:10.1016/j.mtnano.2023.100371 · Cited by 13
Prasad, K., Saggam, A., Guruprasad, K. P., Tillu, G. S., Patwardhan, B., & Satyamoorthy, K. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118261 · Cited by 14
Wang, Q., Ji, H., Hao, Y., Jia, D., Ma, H., Song, C., Qi, H., Li, Z., & Zhang, C. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03824 · Cited by 13
Possible applications of salvianolic acid B against different cancers
Shahzadi, I., Ali, Z., Bukhari, S., Narula, A. S., Mirza, B., & Mohammadinejad, R. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00014 · Cited by 13
“B-cell lymphoma 2 (BCL-2)associated X protein (BAX) and BAK, enhanced caspase-3 level with poly ADP-ribose polymerase (PARP) cleavage and down-regulation of anti-apoptotic proteins such as Bcl-2, which can promote apoptosis [52-55].”
BackgroundKudva, A. K., Raghu, S. V., Achar, P. K., Rao, S., Suresh, S., & Baliga, M. S. (2021) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-021-02589-7 · Cited by 13
“In addition to this, the extrinsic factor, principally the concentration of the carcinogen and length of exposure, can aid cancer formation and progression [13, 14].”
BackgroundTrzeciak, E. R., Zimmer, N., Gehringer, I., Stein, L., Graefen, B., Schupp, J., Stephan, A., Rietz, S., Prantner, M., & Tuettenberg, A. (2022) · Cells · doi:10.3390/cells11060930 · Cited by 13
“However, prolonged elevated ROS levels have been linked to cancer promoting effects, including activating pro-tumor signaling pathways, increasing proliferation, cell survival, and genetic instability [12,13].”
BackgroundResultAdvances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance
Zhang, Z., Chen, B., Liu, Y., Zhang, K., Wei, Z., Dai, Y., & Liu, C. (2025) · ACS Nano · doi:10.1021/acsnano.5c02321 · Cited by 13
Kaur, C., Sahu, S. K., Bansal, K., DeLiberto, L. K., Zhang, J., Tewari, D., & Bishayee, A. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0442 · Cited by 12
Sulukoğlu, E. K., Günaydın, Ş., Kalın, Ş. N., Altay, A., & Budak, H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-02980-5 · Cited by 12
“When there is any problem in this elimination, healthy cells become cancerous (Kirtonia et al. 2020).”
BackgroundLiang, Z., Chen, Q., Pan, L., She, X., & Chen, T. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1978 · Cited by 12
“In the normal physiological metabolism of tumors, the antioxidant systems can regulate the elevated ROS to maintain tumor cell survival (29).”
Angiogenesis causes and vasculogenic mimicry formation in the context of cancer stem cells
Li, Y., Liu, X., Dong, Y., & Zhou, Y. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189323 · Cited by 13
Zhu, S., Liang, J., Zhu, F., Zhang, X., Xu, M., Zhao, K., Zeng, L., & Xu, K. (2021) · Bioscience Reports · doi:10.1042/bsr20202993 · Cited by 12
“signaling during oxidative stress-induced intestinal epithelial cell injury [18, 32].”
BackgroundPezzicoli, G., Filoni, E., Gernone, A., Cosmai, L., Rizzo, M., & Porta, C. (2021) · Cancer Management and Research · doi:10.2147/cmar.s267220 · Cited by 12
Rahman, A. A., Ngah, W. Z. W., Jamal, R., Makpol, S., Harun, R., & Mokhtar, N. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.844199 · Cited by 12
“On the other hand, besides their dual roles in scavenging and/or utilizing reactive oxygen species (ROS) to kill cancer cells (Kirtonia et al., 2020), dietary antioxidants possess other anticancer effects as shown by EGCG inhibiting human lymphoma cell proliferation by modulating the epigenetic modification of p16INK4…”
BackgroundIdentification of a novel oxidative stress-related prognostic model in lung adenocarcinoma
Zhu, Y., Tang, Q., Cao, W., Zhou, N., Jin, X., Song, Z., Zu, L., & Xu, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1030062 · Cited by 12
“Moreover, DNA damage plays an important role in initiating tumorigenesis.”
BackgroundInfluentialLi, J., Yu, L., Zhao, X., & Wu, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196054 · Cited by 11
“In addition, it has also been found that regulation of ROS concentration can reduce the secretion of immunosuppressive cytokines and decrease the summoning of suppressive immune cells, thus avoiding immune escape (15).”
BackgroundQi, Q., Yang, S., Li, J., Li, P., & Du, L. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0371 · Cited by 12
“Besides, ROS can drive angiogenesis by regulating Ang1 and p44/42 MAPK signaling pathways as well as p300, vascular endothelial growth factor-a , hypoxia inducible factor 1 (HIF1), p53, and MMPs (Kirtonia et al., 2020).”
Water-Soluble Alkali Lignin as a Natural Radical Scavenger and Anticancer Alternative
Ivanova, D., Nikolova, G., Karamalakova, Y. D., Semkova, S., Marutsova, V., & Yaneva, Z. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612705 · Cited by 11
“There is indisputable evidence about the role of oxidative stress during cancer initiation as well as during malignant progression process [70,71], and various strategies for the elimination of excess ROS levels have been elaborated.”
BackgroundLiu, B., Li, Y., Xu, Y., Xue, W., & Jin, Z. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00799-5 · Cited by 11
“In general, abnormal lipid metabolism and ROS generation make critical effects on modulating ferroptosis [16, 17].”
BackgroundZhao, Y., Lin, X., Zeng, W., Qin, X., Miao, B., Gao, S., Liu, J., & Li, Z. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08381-w · Cited by 11
Carcinogenicity of metal compounds
Liu, S., & Costa, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823292-7.00014-0 · Cited by 10
Wu, J., Luo, J., Cai, H., Li, C., Lei, Z., Lu, Y., Ni, L., Cao, J., Cheng, B., & Hu, X. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10020079 · Cited by 12
“damage to proteins, lipids, and DNA, generates a large number of oxidative intermediates, increases neutrophil infiltration and protease secretion, activates the regulatory cell death process, and ultimately leads to tissue damage [9].”
BackgroundThe Role of Oxidative Stress in Hypomagnetic Field Effects
Tian, L., Luo, Y., Ren, J., & Zhao, C. (2024) · Antioxidants · doi:10.3390/antiox13081017 · Cited by 10
“TNF receptor-associated factor (TRAF)2 and TRAF6 are then recruited to the ASK1 signalosome, resulting in the activation of the JNK and p38 MAPK pathways [89,90].”
BackgroundYan, Y., Zhang, L., & Feng, L. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102452 · Cited by 10
Zhang, B., Guo, M., Lü, Y., Zeng, Y., & Jiang, J. (2025) · Cancer Medicine · doi:10.1002/cam4.71030 · Cited by 11
“In tissues, elevated intracellular levels of ROS, which may arise from tumorigenic events such as metabolic alterations or oncogene activation, can facilitate tumor initiation or progression [86].”
Zhang, Y., Ji, Y., Tu, Y., & Li, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1642050 · Cited by 10
“Other factors for overcoming DOX depends on targeting special organelles in the cells such as mitochondria due to its function in apoptosis regulation and also, impact of ROS on this organelle (95, 96).”
NRF2 and Primary Cilia: An Emerging Partnership
Martín-Hurtado, A., Lastres‐Becker, I., Cuadrado, A., & García-Gonzalo, F. R. (2020) · Antioxidants · doi:10.3390/antiox9060475 · Cited by 11
Reactive Oxygen Species Signaling Differentially Controls Wound Healing and RegenerationPreprint
Huizen, A. V. V., Hack, S. J., Greene, J. M., Kinsey, L. J., & Beane, W. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.05.487111 · Cited by 13
Pacheco, M. P., Ji, J., Prohaska, T., Garcia, M. M., & Sauter, T. (2022) · Metabolites · doi:10.3390/metabo12121211 · Cited by 9
“While lower concentrations of ROS favour tumorigenesis, higher rates induce apoptosis [42,43].”
BackgroundMitochondrial enzyme FAHD1 reduces ROS in osteosarcoma
Heberle, A., Cappuccio, E., Andric, A., Kuen, T., Simonini, A., & Weiss, A. K. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-60012-x · Cited by 10
Suppression of multiple myeloma by mitochondrial targeting
Aisen, Y., Gatt, M. E., Hertz, R., Smeir, E., & Bar‐Tana, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-83829-2 · Cited by 9
Velmurugan, B. K., Lin, J., Mahalakshmi, B., Lin, C., Chuang, Y., Lo, Y., Ho, H., Hsieh, M., & Chen, M. (2021) · Environmental Toxicology · doi:10.1002/tox.23305 · Cited by 9
“metastasis, it can lead to the overexpression of MMP1/2/9 to enhance metastasis.(19) However, according to the results, dehydrocrenatidine was no affect the production of ROS (data not show).”
BackgroundAPOL3-LDHA axis related immunity activation and cancer ferroptosis induction
Feng, Y., & Dai, Y. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83342 · Cited by 9
“Additionally, high level of ROS in ferroptotic cells may lead to immunosuppressive TME and dampen the cytotoxic capacity of CD8 T cells [7].”
BackgroundTakuathung, M. N., Wongnoppavich, A., Jaijoy, K., Soonthornchareonnon, N., & Sireeratawong, S. (2023) · Natural Product Communications · doi:10.1177/1934578x231176925 · Cited by 8
“At low concentrations, ROS are essential to cellular communication, but excessive ROS production can damage cellular components such as DNA, lipids, and proteins, leading to oxidative stress, inflammation, and ultimately, tumorigenesis.(5,6) Skin cancer or tumorigenesis has been associated with an imbalance between RO…”
BackgroundSmall molecules targeting mitochondria as an innovative approach to cancer therapy
Kamble, O., Chatterjee, R., Abishek, K. G., Chandra, J., Alsayari, A., Wahab, S., Sahebkar, A., Kesharwani, P., & Dandela, R. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111396 · Cited by 8
Hwang, J. H., Park, S. Y., Kang, J., Jung, H. J., Park, J., Maeng, H., Choi, M., Song, H., Song, I., & Oh, S. H. (2025) · Journal of Ginseng Research · doi:10.1016/j.jgr.2025.03.010 · Cited by 8
Su, Z., Li, H., Ye, Z., Zhu, Y., Feng, B. C., Tang, L., & Zheng, G. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116091 · Cited by 8
She, W., Shi, X., Liu, T., Liu, Y., & Liu, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115908 · Cited by 8
AMPK activation; a potential strategy to mitigate TKI-induced cardiovascular toxicity
Safaie, N., Idari, G., Ghasemi, D., Hajiabbasi, M., Alivirdiloo, V., Masoumi, S., Zavvar, M., Majidi, Z., & Faridvand, Y. (2024) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2024.2426494 · Cited by 8
“…and activator of transcription 3 (StAt3), along with the inactivation of phosphatases such as protein tyrosine phosphatase B1 (PtPB1), protein phosphatase A2 (PPA2), and phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and tensin homolog (PteN) (Kirtonia et al. 2020, Feng et al. 2024).”
Multifactorial Distress, the Warburg Effect, and Respiratory and pH Imbalance in Cancer Development
Drochioiu, G. (2023) · Stresses · doi:10.3390/stresses3020036 · Cited by 10
Fan, Y., Zhao, Q., Wei, Y., Wang, H., Ga, Y., Zhang, Y., & Hao, Z. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116806 · Cited by 8
Lu, X., & Jin, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1486783 · Cited by 7
Munusamy, M. A., Bharathi, M., Alarfaj, A., Hussein-Al-Ali, S., Nagaiya, R., & Subbarayan, S. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106037 · Cited by 6
Phospholipid Metabolism Reprogramming of Cancer Stem Cells and Its Impacts on Stemness
Wang, Q., Cai, L., Tang, S., Pan, D., Wang, Z., Chen, Q., Zhou, Y., & Shen, Y. (2025) · Biocell · doi:10.32604/biocell.2025.060045 · Cited by 8
“Studies have found that the anti-tumor effect can be enhanced by inducing ferroptosis of tumor cells, and this anti-cancer strategy has broad prospects [169,170].”
Meng, Y., Zhou, L., Xia, Y., Jia, C., & Huang, L. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118703 · Cited by 12
Sadwal, S., Bharati, S., Dar, Z. A., & Kaur, S. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117124 · Cited by 7
Zhang, K., Mao, X., Zhao, H., Bianco, A., Ge, S., & Ma, B. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.156544 · Cited by 7
Sin, Z. W., Mohan, C. D., Chinnathambi, A., Govindasamy, C., Rangappa, S., Rangappa, K. S., Jung, Y. Y., & Ahn, K. S. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2059092 · Cited by 7
Mechanism of Action and Implication of Naphthoquinone as Potent Anti-trypanosomal Drugs
Rani, R., Sethi, K., Gupta, S., Varma, R. S., & Kumar, R. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220912101332 · Cited by 8
Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?
Hao, S., Cai, D., Gou, S., Li, Y., Liu, L., Tang, X., Chen, Y., Zhao, Y., Shen, J., Wu, X., et al. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230719142202 · Cited by 7
Long, G., Li, Z., Gao, Y., Zhang, X., Cheng, X., Daniel, I. E., Zhang, L., Wang, D., & Li, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34381 · Cited by 7
“ROS and angiogenesis are also connected, suggesting a potential relationship between angiogenesis and ferroptosis [40].”
Nanoparticle-driven reactive oxygen species therapy: A new frontier in osteosarcoma treatment
He, L., Habibović, P., & van Rijt, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114289 · Cited by 6
Chen, Y., Shi, H., Xiao, M., Pan, H., Yu, X., Zhu, Y., Yang, J., Wang, W., Xu, J., Yu, X., et al. (2026) · Biomarker Research · doi:10.1186/s40364-026-00902-6 · Cited by 6
7-O-tyrosyl Silybin Derivatives as a Novel Set of Anti-Prostate Cancer Compounds
Romanucci, V., Pagano, R., Kandhari, K., Zarrelli, A., Petrone, M. C., Agarwal, C., Agarwal, R., & Fabio, G. D. (2024) · Antioxidants · doi:10.3390/antiox13040418 · Cited by 6
“New derivatives of SilA, SilB, as well as Sil have been synthesized starting from silibinin ( 9ab ), silybins ( 9a and 9b ), and suitably protected tyrosol-based phenols ( 6 , 7 , and 8 ).”
Backgrounddos Reis, A. S., Paltian, J. J., Domingues, W. B., Novo, D. L. R., Bolea‐Fernandez, E., Acker, T. V., Campos, V. F., Luchese, C., Vanhaecke, F., Mesko, M. F., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04430-y · Cited by 7
“Redox homeostasis significantly affects normal cellular functionality [33].”
Li, Y., Zhang, L., Xu, G., Xu, G., Chen, J., Zhao, K., Li, M., Jin, J., Peng, C., Wang, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1493528 · Cited by 6
“ROS has been indicated to be crucial secondary messengers governing various cellular biological processes, including proliferation, angiogenesis, differentiation, metastasis, autophagy, drug resistance, immune response, and cancer stem cells (12).”
Dietary rational targeting of redox-regulated genes
Bagyi, J., Sripada, V., Aidone, A. M., Lin, H., Ruder, E. H., & Crawford, D. R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.021 · Cited by 6
Khanna, T. R., Dave, A., Purani, S. S., Vedamurthy, J., Jivani, D., & Robin, P. (2022) · Journal of Natural Remedies · doi:10.18311/jnr/2022/28740 · Cited by 6
Wang, Y., Charkoftaki, G., Davidson, E. A., Orlicky, D. J., Tanguay, R. L., Thompson, D. C., Vasiliou, V., & Chen, Y. (2022) · Current Opinion in Environmental Science & Health · doi:10.1016/j.coesh.2022.100389 · Cited by 7
Potential Diets to Improve Mitochondrial Activity in Amyotrophic Lateral Sclerosis
Yoshikawa, S., Taniguchi, K., Sawamura, H., Ikeda, Y., Tsuji, A., & Matsuda, S. (2022) · Diseases · doi:10.3390/diseases10040117 · Cited by 7
“Therefore, the control of the mitochondrial ROS level is of key relevance for maintaining cellular homeostasis [9].”
BackgroundPositive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects
Ribeiro, E., & Vale, N. (2024) · Targets · doi:10.3390/targets2020009 · Cited by 7
“Additionally, there has been an extensive review of molecules that manage ROS homeostasis for cancer treatment [147,148].”
BackgroundCarpena, M., Garcia‐Oliveira, P., Pereira, A. G., Soria-López, A., Chamorro, F., Collazo, N., Jarboui, A., Simal‐Gándara, J., & Prieto, M. A. (2021) · Reference series in phytochemistry · doi:10.1007/978-3-030-45299-5_35-1 · Cited by 7
Mitochondrial dysfunction and its impact on pyroptosis and ferroptosis cross talk in glioma cells
Guo, Y., Liu, H., Gao, Z., Zhou, Z., Zhao, Y., Wang, M., Li, S., Xiang, W., Liao, J., & Zhou, J. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf099 · Cited by 5
Roles of hypoxia in tumor progression and novel strategies for cancer treatment
Khan, B. D., Nhan, T. N. T., Chau, H. N. M., & Nhi, N. T. Y. (2022) · Biomedical Research and Therapy · doi:10.15419/bmrat.v9i10.774 · Cited by 8
Metadata
- Authors
- Kirtonia, A., Sethi, G., & Garg, M.
- Affiliations
- Amity University (IN)
- National University of Singapore (SG)
- Corresponding author
- Sethi, Gautam
- Garg, Manoj
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2020-05-01
- Volume
- 77
- Issue
- 22
- Pages
- 4459-4483
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC11105050
- OpenAlex
- W3022746266
- Cited by
- 452
- References
- 257
- Citations by year
- 2026: 33 · 2025: 45 · 2024: 90 · 2023: 72 · 2022: 106 · 2021: 80 · 2020: 26
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology , Ministry of Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- reactive oxygen species, carcinogenesis, redox homeostasis, oxidative stress, metastasis, angiogenesis, oncogenic signaling, DNA mutations, tumor microenvironment, cancer stem cells, drug resistance, anticancer agents, immunotherapy, radiotherapy, chemotherapy
- MeSH terms
- Animals, Humans, Neoplasm Recurrence, Local, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review